Rel-1-ethyl-4-((4-((1s,4r)-4-pentylcyclohexyl)phenyl)ethynyl)benzene

Catalog No. :
ACBQMA254
CAS No. :
100582-74-9
Molecular Formula :
C27H34
Molecular Weight :
358.57

IUPAC Name:1-ethyl-4-((4-((1s,4r)-4-pentylcyclohexyl)phenyl)ethynyl)benzene

Rel-1-ethyl-4-((4-((1s,4r)-4-pentylcyclohexyl)phenyl)ethynyl)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$86.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-1-ethyl-4-((4-((1s,4r)-4-pentylcyclohexyl)phenyl)ethynyl)benzene
IUPAC Name1-ethyl-4-((4-((1s,4r)-4-pentylcyclohexyl)phenyl)ethynyl)benzene
Molecular FormulaC27H34
Molecular Weight358.57
SMILESCCCCC[C@H]1CC[C@H](C2=CC=C(C#CC3=CC=C(CC)C=C3)C=C2)CC1
InChI KeyCBSZFLVBAIAWNJ-OJBMAJLDSA-N
SynonymBenzene,1-ethyl-4-[2-[4-(trans-4-pentylcyclohexyl)phenyl]ethynyl]-;Pentyl cyclohexyl p-ethyl Diphenylacetylene;Rel-1-ethyl-4-((4-((1s,4r)-4-pentylcyclohexyl)phenyl)ethynyl)benzene
CAS No.100582-74-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H413
Precautionary Statement(s)
P264-P273-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACBQMA254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHGJC259 route compound structure diagram
    ACHGJC25925309-64-2 In Stock
  4. Then
  5. ACBQMA254 route product structure diagram
    ACBQMA254100582-74-9 In Stock
Inquiry

2. ACBQMA254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZOIF584 route compound structure diagram
    ACZOIF58440307-11-7 In Stock
  2. Plus
  3. ACVGHF398 route compound structure diagram
    ACVGHF39879832-89-6 In Stock
  4. Then
  5. ACBQMA254 route product structure diagram
    ACBQMA254100582-74-9 In Stock
Inquiry

Comments (0)